ITMTF Stock DD Intertainment Media, Inc. 07/22/2014 07:47:12

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
ITMTF Intertainment Media, Inc. $ITMTF Company Overview

Stock Message Board http://investorshangout.com/search?q=ITMTF&am...mp;yt1=Go!

Last Updated: 07/22/2014 07:47:08

Current Price and Quotes
Last Price 0.0398
Previous Close 0.0398 Open N/A
Daily Range N/A - N/A 52wk Range 0.027 - 0.107
Volume 0 Dividend N/A
Average Vol (3m) 26,268 Yield N/A




Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011
Total Revenue 4,127 4,642 5,517
Cost of Revenue 2,751 3,525 3,864
Gross Profit 1,376 1,116 1,653
Operating Expenses

Research and Development 2,024 1,818 1,265
Sales, General and Admin. 13,582 20,180 12,488
Non-Recurring Items - - -
Other 4,417 3,917 1,086
Operating Income (18,648) (24,799) (13,186)
Income From Continuing Operations

Add'l Income/Expense Items (4,287) (2,433) 30
Earnings Before Interest and Tax (23,983) (27,481) (13,155)
Interest Expense 712 216 935
Earnings Before Tax (24,695) (27,697) (14,090)
Income Tax (757) (3,551) (6)
Minority Interest (193) (172) (31)
Equity Earnings Unconsolidated Subsidiary (1,047) (250) -
Net Income Cont. Operations (24,792) (24,224) (14,052)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (24,792) (24,224) (14,052)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (23,745) (23,974) (14,052)

Recent News

Jul 8, 2014 Intertainment Media Executes Agreements to Sell Subsidiary Magnum Printing
May 7, 2014 Intertainment Media Subsidiary Ortsbo to Receive $2 Million in Equity From Yappn for IP Rights Exercise


ITMTF Intertainment Media, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ITMTF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ITMTF/quote
Stock Chart http://www.otcmarkets.com/stock/ITMTF/chart
Company Info http://www.otcmarkets.com/stock/ITMTF/company-info
Recent News http://www.otcmarkets.com/stock/ITMTF/news
Financials http://www.otcmarkets.com/stock/ITMTF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ITMTF/filings
Short Sales http://www.otcmarkets.com/stock/ITMTF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ITMTF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ITMTF/research
Summary http://finance.yahoo.com/q?s=ITMTF
Historical Prices http://finance.yahoo.com/q/hp?s=ITMTF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ITMTF
Basic Chart http://finance.yahoo.com/q/bc?s=ITMTF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ITMTF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ITMTF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ITMTF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ITMTF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ITMTF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ITMTF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ITMTF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ITMTF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ITMTF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ITMTF
Balance Sheet http://finance.yahoo.com/q/bs?s=ITMTF
Cash Flow http://finance.yahoo.com/q/cf?s=ITMTF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ITMTF
Market Watch http://www.marketwatch.com/investing/stock/ITMTF
Bloomberg http://www.bloomberg.com/quote/ITMTF:US
Morningstar http://quotes.morningstar.com/stock/s?t=ITMTF
Bussinessweek http://investing.businessweek.com/research/st...cker=ITMTF
Barchart http://www.barchart.com/quotes/stocks/ITMTF
OTC Short Report http://otcshortreport.com/index.php?index=ITMTF
Investopedia http://www.investopedia.com/markets/stocks/ITMTF/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading